Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy ##### Up next ![ThunderSoft Showcases Edge AI Innovations at embedded world 2026, Highlighting the Rise of Intelligent Edge Systems](https://i0.wp.com/mma.prnasia.com/media2/2933436/image2.jpg?resize=200%2C110&ssl=1 "ThunderSoft Showcases Edge AI Innovations at embedded world 2026, Highlighting the Rise of Intelligent Edge Systems") [](https://thailandbusinessnews.net/press-release/thundersoft-showcases-edge-ai-innovations-at-embedded-world-2026-highlighting-the-rise-of-intelligent-edge-systems/) ###### [ThunderSoft Showcases Edge AI Innovations at embedded world 2026, Highlighting the Rise of Intelligent Edge Systems](https://thailandbusinessnews.net/press-release/thundersoft-showcases-edge-ai-innovations-at-embedded-world-2026-highlighting-the-rise-of-intelligent-edge-systems/) Published on 13 March 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) SHANGHAI, March 13, 2026 /PRNewswire/ — On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This breakthrough marks UX-GIP001 as the first iPSC-derived allogeneic epilepsy cell therapy approved in the U.S. and simultaneously establishes it as China’s pioneering cell therapy for epilepsy to advance into the clinical stage. Epilepsy is a common neurological disorder affecting over 70 million people worldwide. It is prevalent in infants and the elderly, and can be triggered by events like brain injury or surgical trauma. While resection and neurostimulation help some, they have significant side effects, so innovative therapies are urgently needed to selectively target epileptic foci while preserving healthy tissue and avoiding drug effects. In epilepsy patients, impaired GABAergic interneurons drive neural hyperexcitability and seizures. UX-GIP001 targets this by leveraging Unixell’s proprietary stem cell technology to produce inhibitory neural progenitor cells through directed differentiation. After transplantation, it reconstructs inhibitory circuits, suppressing seizures. The preclinical studies have demonstrated the efficacy of UX-GIP001 in epileptic animal models and its safety profile, supporting progression to clinical trials. Phase 1 study is planned to evaluate the safety, tolerability, and efficacy of UX-GIP001 for drug-resistant epilepsy patients. With UX-GIP001 advancing into the clinical stage, Unixell Biotech has established a core product pipeline targeting Parkinson’s disease and epilepsy—two areas burdened by significant unmet clinical needs. The company is simultaneously advancing both autologous and allogeneic cellular therapy strategies, building a comprehensive product matrix that spans diverse indications and treatment scenarios. Leveraging its internationally leading human pluripotent stem cell R&D platform and sophisticated neural cell directed differentiation technology, Unixell Biotech is continuously expanding its capabilities to develop and translate cellular drugs for multiple indications. Driven by scientific evidence, the company is dedicated to building a long-term competitive, innovative cellular therapy platform, striving to deliver safer and more effective breakthrough treatment options for patients worldwide! **About UniXell Biotech** Shanghai UniXell Biotechnology Co., Ltd. was established in 2021, specializing in the research and development of cell therapy drugs for neurological diseases, including Parkinson’s disease and epilepsy. The company is equipped with a 4,000-square-meter R&D center and GMP facilities. It has developed four major innovative technology platforms based on reprogramming technology, stem cell differentiation technology, SISBAR lineage tracing technology, and high-precision gene editing. These platforms facilitate the development and production of neural cell drugs with higher purity and more stable efficacy, ensuring efficient and safe clinical treatment outcomes. As of the present, UniXell has successfully obtained several rounds of financing from esteemed investors, such as Hillhouse Capital, CDH Investments, Fosun Group, Sherpa Healthcare Partners, TF Capital and Tasly Capital, among others. This underscores the robust market confidence in its pioneering therapeutic solutions and its potential for growth. **Contact UniXell Biotechnology Co., Ltd.** [Source link ](http://www.prnasia.com/story/archive/4909647_CN09647_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/atlantis-sanya-readies-for-summer-tourism-market/) ![Atlantis Sanya Readies for Summer Tourism Market](https://i0.wp.com/mma.prnasia.com/media2/2989767/photo_1.jpg?resize=260%2C140&ssl=1 "Atlantis Sanya Readies for Summer Tourism Market") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Atlantis Sanya Readies for Summer Tourism Market Multi-Dimensional Upgrades Elevate Premium Family Vacations SANYA, China, May 29, 2026 /PRNewswire/ —… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 28, 2026 [](https://thailandbusinessnews.net/press-release/tessan-to-unveil-a-new-vision-for-power-connection-challenging-industry-conventions-at-ifa-2025/) ![TESSAN to Unveil a New Vision for Power Connection, Challenging Industry Conventions at IFA 2025](https://i0.wp.com/r2.thailandbusinessnews.net/2025/08/Meet_TESSAN_at_IFA_2025.jpg?resize=260%2C140&ssl=1 "TESSAN to Unveil a New Vision for Power Connection, Challenging Industry Conventions at IFA 2025") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## TESSAN to Unveil a New Vision for Power Connection, Challenging Industry Conventions at IFA 2025 BERLIN, Aug. 27, 2025 /PRNewswire/ — TESSAN, a global innovator in travel… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - August 27, 2025 [](https://thailandbusinessnews.net/press-release/sanya-2026-ticketing-system-launched-118000-discounted-tickets-on-sale-globally/) ![Sanya 2026 Ticketing System Launched: 118,000 Discounted Tickets on Sale Globally](https://i0.wp.com/mma.prnasia.com/media2/2943276/The_6th_Asian_Beach_Games_Sanya_2026_30_day_countdown_press.jpg?resize=260%2C140&ssl=1 "Sanya 2026 Ticketing System Launched: 118,000 Discounted Tickets on Sale Globally") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Sanya 2026 Ticketing System Launched: 118,000 Discounted Tickets on Sale Globally SANYA, China, March 26, 2026 /PRNewswire/ — On March 23, at the… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 26, 2026 ##### Most Read - [![BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/bitraser-receives-frost-sullivans-2026-global-customer-value-leadership-recognition-for-data-erasure-for-used-electronics/ "BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics") [BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics](https://thailandbusinessnews.net/press-release/bitraser-receives-frost-sullivans-2026-global-customer-value-leadership-recognition-for-data-erasure-for-used-electronics/ "BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics") - [![Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection](https://i0.wp.com/r2.thailandbusinessnews.net/2025/03/1742866040_Power_Up_Teyvat_Journey_UGREEN_Launches_Genshin_Impact_Co_Branded_Charging.jpg?fit=600%2C324&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/power-up-the-teyvat-journey-ugreen-launches-genshin-impact-co-branded-charging-collection-4/ "Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection") [Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection](https://thailandbusinessnews.net/press-release/power-up-the-teyvat-journey-ugreen-launches-genshin-impact-co-branded-charging-collection-4/ "Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection") - [![Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tuya-reports-second-quarter-2025-unaudited-financial-results-and-declaration-of-cash-dividend/ "Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend") [Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend](https://thailandbusinessnews.net/press-release/tuya-reports-second-quarter-2025-unaudited-financial-results-and-declaration-of-cash-dividend/ "Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend") - [![CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/csl-and-alentis-announce-global-partnership-to-develop-and-commercialise-lixudebart-for-rare-kidney-and-liver-diseases/ "CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases") [CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases](https://thailandbusinessnews.net/press-release/csl-and-alentis-announce-global-partnership-to-develop-and-commercialise-lixudebart-for-rare-kidney-and-liver-diseases/ "CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases") - [![FGR advances carbon fibre commercialisation with Aeropreg agreement](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/fgr-advances-carbon-fibre-commercialisation-with-aeropreg-agreement/ "FGR advances carbon fibre commercialisation with Aeropreg agreement") [FGR advances carbon fibre commercialisation with Aeropreg agreement](https://thailandbusinessnews.net/press-release/fgr-advances-carbon-fibre-commercialisation-with-aeropreg-agreement/ "FGR advances carbon fibre commercialisation with Aeropreg agreement") - [![Celaid Therapeutics Completes Second Close of Series B Financing Round](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/celaid-therapeutics-completes-second-close-of-series-b-financing-round/ "Celaid Therapeutics Completes Second Close of Series B Financing Round") [Celaid Therapeutics Completes Second Close of Series B Financing Round](https://thailandbusinessnews.net/press-release/celaid-therapeutics-completes-second-close-of-series-b-financing-round/ "Celaid Therapeutics Completes Second Close of Series B Financing Round") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/evident-completes-acquisition-of-crestoptics-s-p-a/) ## EVIDENT Completes Acquisition of CrestOptics S.p.A. NEEDHAM, Mass., Oct. 5, 2026 /PRNewswire/ — Evident announced today that it… [](https://thailandbusinessnews.net/press-release/sovereign-wealth-fund-institute-announces-first-i20-summit-alongside-g20-leaders-summit-targets-us5tn-capital-deployment-into-us-2/) ![Sovereign Wealth Fund Institute announces first I20 Summit alongside G20 Leaders' Summit, targets UStn capital deployment into US](https://i0.wp.com/mmx.prnasia.com/media/MS2001905/Image-1.jpg?resize=260%2C140&ssl=1 "Sovereign Wealth Fund Institute announces first I20 Summit alongside G20 Leaders' Summit, targets UStn capital deployment into US") ## Sovereign Wealth Fund Institute announces first I20 Summit alongside G20 Leaders' Summit, targets US$5tn capital deployment into US Five-day event set for Miami (11–15 December 2026) alongside the G20 Leaders’… [](https://thailandbusinessnews.net/press-release/nx-group-launches-us-5-day-cross-for-u-s-delivery-within-5-days-expanding-nx-ocean-fast-track-capabilities/) ## NX Group Launches "US 5-Day Cross" for U.S. Delivery Within 5 Days, Expanding "NX Ocean Fast Track" Capabilities TOKYO, Oct. 5, 2026 /PRNewswire/ — NIPPON EXPRESS HOLDINGS, INC. has launched… [](https://thailandbusinessnews.net/press-release/cymulate-receives-frost-sullivans-2026-indian-competitive-strategy-leadership-recognition-for-advancing-continuous-security-validation/) ## Cymulate Receives Frost & Sullivan's 2026 Indian Competitive Strategy Leadership Recognition for Advancing Continuous Security Validation The recognition highlights Cymulate’s competitive strategy, continuous…